Alternatives to Axsome Therapeutics

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Biopharmaceutical company developing innovative botanical drugs for addiction treatment.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

AI-powered platform accelerating biological research and drug discovery.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.

A global pharmaceutical company focused on developing and marketing innovative treatments.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Physics-based software platform for molecular discovery and design in life and materials sciences.

Develops a computational model of the human body for drug discovery and development.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Enabling pharmaceutical companies to deliver medications directly to patients at scale.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered research assistant for scientific literature review and data extraction.

Connects patients, providers, pharmacies, and life science companies to improve treatment affordability.

Developing novel therapeutics to restore gut lymphatic function.

Enzyme-based technology to break down alcohol in the stomach.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A telehealth company providing personalized healthcare for men and women.

International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Alcon is a global leader in eye care, providing a broad portfolio of products to enhance sight and improve lives.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

RD-Biotech develops innovative solutions for drug discovery and development using advanced biotechnology.

Accelerating the development of breakthrough new medicines and medical technologies.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing oral small molecule medicines for immunological and chronic diseases.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).